genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Coronavirus
Rough Surf Ahead for California
Cancer
Alpine’s Gold Standard Approach to Drug Development
Biomarkers
Precision M&A: Invitae Eyes Growth in Personalized Cancer Tests, Services with…
Gene Therapy
Obsidian’s SWFT Response to COVID-19
Antibody Drug Conjugates
AbCellera’s CEO: Flattening the Curve of Technology Development
News
Neuroscience
Proteins Required for Brain and Heart Function Activated by Pickled Capers
Drug Discovery
Red Blood Cells Harnessed as Nanoparticle Carriers for Vaccines
Autism
Autistic Traits in Mice Associated with Blood Vessel Defects
OMICs
Single-Cell Company Berkeley Lights Sets Terms for $153M IPO
Cancer
Tumor Microenvironment Analyzed by New Nano-Radiomics Approach
Insights
All
Trends for 2020
Coronavirus
Bacteriophages Could Be a Potential Game Changer in the Trajectory of…
Bioprocessing
Digital Biomanufacturing Needs a Digital Supply Chain
Bioprocessing
Continually Collecting Virions for Manufacturing Biotech Products
Bioprocessing
AI Promises to Accelerate Process Characterization
A-Lists
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Coronavirus
Catching Up to Coronavirus: Top 60 Treatments in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Drug Discovery
Red Blood Cells Harnessed as Nanoparticle Carriers for Vaccines
OMICs
Single-Cell Company Berkeley Lights Sets Terms for $153M IPO
Cancer
Tumor Microenvironment Analyzed by New Nano-Radiomics Approach
Coronavirus
Rough Surf Ahead for California
Magazine
July 2020 Vol. 40 No. 7
Rosalind Franklin the Scientist
July 2020 Vol. 40 No. 7
COVID-19 Research: Women Are Changing the Face of the Pandemic
July 2020 Vol. 40 No. 7
CRISPR Screening Explores New Dimensions
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
Commentary
Clues to Healthier Aging in Cellular Senescence
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Keynote Webinars
Life in the Time of Coronavirus
Upcoming Webinars
Uncover the True Identity of Your Particles with Comprehensive Particle Investigation
On Demand Webinars
GEN Live: COVID-19: Talking Next-Gen Diagnostics
Tutorial
Cultivation of Diverse and Rare Bacteria from Human Gut Microbiome
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Companies
GlaxoSmithKline
GlaxoSmithKline
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
GlaxoSmithKline
GSK Invests $250M in Vir as Companies Partner on COVID-19 Candidates
GlaxoSmithKline
GSK, Immatics Ink Up-to-$1B Cancer Immunotherapy Collaboration
GlaxoSmithKline
Gilead Partnering with China on Trial of Remdesivir as Coronavirus Treatment
GlaxoSmithKline
Merck Acquires TRPML1 Agonist Developer Calporta for Up to $576M
GlaxoSmithKline
GSK Completes $120M Manufacturing Expansion in Upper Merion, PA
GlaxoSmithKline
GSK Advances Arthritis Candidate into Phase III, Triggering €22M Milestone Payment...
GlaxoSmithKline
GSK Partners with CRISPR Pioneers Doudna, Weissman to Launch Laboratory for...
GlaxoSmithKline
Thermo Fisher to Acquire API Plant in Cork, Ireland from GSK
GlaxoSmithKline
GSK to Co-Develop Merck KGaA’s Cancer Immunotherapy Candidate M7824 in $4.2B...
GlaxoSmithKline
Orchard Therapeutics Plans 3 Approval Submissions, In-House Manufacturing by 2021
GlaxoSmithKline
GSK to Acquire PARP Inhibitor Developer Tesaro for $5.1B
GlaxoSmithKline
GSK Invests $300M in 23andMe as Companies Collaborate on Drug Development
GlaxoSmithKline
GSK Sells Psoriasis/Dermatitis Candidate Tapinarof to Dermavant
GlaxoSmithKline
After Second Phase III Failure, AstraZeneca Retreats from COPD Filing Plans...
GlaxoSmithKline
GSK Hands Off Rare Disease Gene Therapy Portfolio to Orchard Therapeutics
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![GlaxoSmithKline (GSK) has made a $300 million equity investment in 23andMe under a collaboration designed to accelerate development of new therapies for both companies by using genetic data to identify new drug targets. [Source: © fotoliaxrender/Fotolia]](https://www.genengnews.com/wp-content/uploads/2018/08/Aug5_2014_56448122_DNAblue_NovelDiagnosticGenomic12114111424-324x160.jpg "GSK Invests $300M in 23andMe as Companies Collaborate on Drug Development")
